Biosensors

Healthcare is undergoing a sensing revolution; medical device manufacturers are improving diabetes outcomes using continuous glucose monitoring to measure, predict and manage blood glucose levels, and pharmaceutical companies are using wearable sensors to generate real-time healthcare efficacy data for clinical trials. The data produced can be analysed at an individual level to deliver tailored personalised therapies, and at a population level to identify trends and predict outcomes. These advantages are contingent on the ability to sense rich, accurate data. Biosensors provide this data, responding to the presence of a biological analyte and converting this response into a useful signal.

Biotechnology companies, pharmaceutical manufacturers, and sensor firms are all investing in research and development to eliminate time-consuming sample enrichment, move from discrete tests to real-time monitoring, advance non-invasive, minimally invasive, and implantable measurement techniques, and reduce the patient burden and sensing cost per-day.

TTP works with clients to design and develop innovative biosensors that enable the successful measurement of previously undetectable physiological signals.